Derek J. Maetzold - Pres. & Chief Exec. Officer, Director at Castle Biosciences Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Pres. & Chief Exec. Officer, Director
Stock Symbol
CSTL on Nasdaq
Industry
Services-Medical Laboratories
All Insider Reports
All Insider Reports

Derek J. Maetzold - trading volume in the past year for Castle Biosciences Inc

Holdings reported by Derek J. Maetzold for Castle Biosciences Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 123K $3.53M $28.76 Dec 17, 2024 By DJM Grantor Retained Annuity Trust No. 5
Common Stock 84.8K $2.44M $28.76 Dec 17, 2024 Direct
Common Stock 73.1K $2.1M $28.76 Dec 17, 2024 By The Maetzold Descendants 2020 Trust
Performance-Based Stock Unit 67K $1.8M $26.83 Aug 9, 2024 Direct Common Stock
Common Stock 62.5K $1.8M $28.76 Dec 17, 2024 By Derek Maetzold 2020 Irrevocable Trust
Common Stock 26.1K $752K $28.76 Dec 17, 2024 By DJM Grantor Retained Annuity Trust No. 6
Restricted Stock Units 15.4K $457K $29.63 Dec 10, 2024 Direct Common Stock
Common Stock 5.71K $164K $28.76 Dec 17, 2024 By The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk
Common Stock 5.7K $164K $28.76 Dec 17, 2024 By The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold
Common Stock 5.7K $164K $28.76 Dec 17, 2024 By The Maetzold 2018 Remainder Trust FBO John Derek Maetzold
Common Stock 5.7K $164K $28.76 Dec 17, 2024 By The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold
Stock option (right to buy) 0 $0 $3.72 Mar 5, 2024 Direct Common Stock

Transactions reported by Derek J. Maetzold for Castle Biosciences Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.